The Food and Drug Administration-approved antipsychotic drug trifluoperazine, a calmodulin antagonist, inhibits viral replication through PERK-eIF2α axis

Yizhi Mao(Sun Yat-sen University), Chunjie Sheng(Sun Yat-sen University)
Frontiers in Microbiology
November 1, 2022
Cited by 5


Related Papers